Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-CD70 Antibody (3T581) is an antibody targeting CD70. Anti-CD70 Antibody (3T581) can be used in ELISA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $209 | 7-10 days | 7-10 days | |
| 100 μL | $348 | 7-10 days | 7-10 days |
| Description | Anti-CD70 Antibody (3T581) is an antibody targeting CD70. Anti-CD70 Antibody (3T581) can be used in ELISA. |
| Synonyms | TNFSF7G, TNFSF7, CD70 molecule, CD70, CD27LG, CD27-L, CD27 Ligand, Ki-24 antigen |
| Ig Type | Human IgG1 |
| Clone | 3T581 |
| Reactivity | Human |
| Verified Activity | 1. The Binding Activity of Human CD70 with Anti-CD70 recombinant antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CD70 at 2 μg/mL can bind Anti-CD70 recombinant antibody, the EC50 is 1.642-2.005 ng/mL. 2. Greater than 95% as determined by SEC-HPLC. |
| Application | |
| Antibody Type | Monoclonal |
| Subcellular Localization | Membrane; Single-pass type II membrane protein. |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| Research Background | Cytokine which is the ligand for CD27. The CD70-CD27 pathway plays an important role in the generation and maintenance of T cell immunity, in particular during antiviral responses. Upon CD27 binding, induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human CD70 Protein |
| Antigen Species | Human |
| Gene Name | CD70 |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Cancer |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.